“Therapeutic and Adverse Effects of Standard-Dose and Low-Dose Meglumine Antimoniate During Systemic Treatment of Syrian Cutaneous Leishmaniasis Patients”. Journal of Pakistan Association of Dermatologists, vol. 24, no. 2, Dec. 2016, pp. 115-21, https://doi.org/10.66344/jpad.v24i2.189.